| 261 |
|
Corrections - To: Cerebral artery air embolism following an esophagogastroscopy: a case report/
|
|
Advanstar Communications [etc.]
|
2001
|
|
|
|
| 262 |
|
Corrections - To: Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy/
|
|
Advanstar Communications [etc.]
|
2001
|
|
|
|
| 263 |
|
Corrections - To: Familial occipital calcifications, hemorrhagic strokes, leukoencephalopathy, dementia, and external carotid dysplasia/
|
|
Advanstar Communications [etc.]
|
2001
|
|
|
|
| 264 |
|
Corrections - To: Fulminant liver failure during interferon beta treatment of multiple sclerosis/
|
|
Advanstar Communications [etc.]
|
2001
|
|
|
|
| 265 |
|
Corrections - To: Headache types and panic disorders: Directionality and specificity/
|
|
Advanstar Communications [etc.]
|
2001
|
|
|
|
| 266 |
|
Corrections - To: Past adult lead exposure is associated with longitudinal decline in cognitive function/
|
|
Advanstar Communications [etc.]
|
2001
|
|
|
|
| 267 |
|
Corrections - To: PRISMS-4: Long-term efficacy of interferon-b-1a in relapsing MS/
|
|
Advanstar Communications [etc.]
|
2001
|
|
|
|
| 268 |
|
Correction - To: Chenodeoxycholic treatment of cerebrotendinous anthomatosis/
|
|
Advanstar Communications [etc.]
|
2001
|
|
|
|
| 269 |
|
Correction - To: Corpus callosum size in autism/
|
|
Advanstar Communications [etc.]
|
2000
|
|
|
|
| 270 |
|
Correction - To: Early development of intractable epilepsy in children: A prospective study/
|
|
Advanstar Communications [etc.]
|
2001
|
|
|
|
| 271 |
|
Correction - To: Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension/
|
|
Advanstar Communications [etc.]
|
2000
|
|
|
|
| 272 |
|
Correction - To: HMG-CoA reductase inhibitors (statins): A promising approach to stroke prevention/
|
|
Advanstar Communications [etc.]
|
2001
|
|
|
|
| 273 |
|
Correction - To: Practiee parameter: Evidence-based guidelines for migraine headache (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology/
|
|
Advanstar Communications [etc.]
|
2001
|
|
|
|
| 274 |
|
Correction - To: Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced Parkinson's disease/
|
|
Advanstar Communications [etc.]
|
2001
|
|
|
|
| 275 |
|
Correction - To: Treatment of agitation in AD: A randomized, placebo-controlled clinical trial/
|
|
Advanstar Communications [etc.]
|
2001
|
|
|
|
| 276 |
|
Correlates of MS disability assessed in vivo using aggregates of MR quantities/
|
Mainero, C
|
Advanstar Communications [etc.]
|
2001
|
|
|
|
| 277 |
|
Correlation of statin-increased platelet APP ratios and reduced blood lipids in AD patients/
|
Baskin, F
|
Advanstar Communications [etc.]
|
2003
|
|
|
|
| 278 |
|
Correspondence -/
|
|
Advanstar Communications [etc.]
|
2001
|
|
|
|
| 279 |
|
Correspondence - A 1-year controlled trial of acetyl-L-carnitine in early-onset AD/
|
Barrett, A M
|
Advanstar Communications [etc.]
|
2001
|
|
|
|
| 280 |
|
Correspondence - Abnormal vergence with upper brainstem infarcts: Pseudoabducens palsy/
|
Wiest, G
|
Advanstar Communications [etc.]
|
2001
|
|
|
|